Juno Therapeutics, Inc.

Juno Therapeutics, Inc. (United States) is linked to 1 FDA-registered manufacturing site. 3 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Juno Therapeutics, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/juno-therapeutics-inc

Overview

Juno Therapeutics, Inc. is a subsidiary of Bristol-Myers Squibb Company that focuses on developing innovative immunotherapies for the treatment of cancer. The company leverages advanced technologies to enhance the body’s immune system in targeting cancer cells.

Therapeutic areas

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to Juno Therapeutics, Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

3 FDA enforcement records linked to this company.

  • 4832023-09-20

    Written procedures not established/followed

  • 4832023-09-20

    Procedures not in writing, fully followed

  • 4832023-09-20

    Procedures for sterile drug products

For suppliers

Is this Juno Therapeutics, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.